Jouveinal, S.a.

L'oreal

Warner-Lambert Company

Institut De Recherche Jouveinal S.a.

Institut De Recherche Jouveinal

Alain P Calvet

Jean-Louis Junien

Xavier B Pascaud

Gilbert G Aubard

Claude J Gouret

Francois J Roman

Agnes G Grouhel

James P Hudspeth

Yuan Lin

Henry L Jacobelli

Agnes M Grouhel

Henry Jacobelli

Pierre Riviere

Francedillaois-Joseph Roman

Francois F Roman

Jacques Bure

Henri Jacobelli

Ives R Pascal

Claude D Soulard

Jean-Pierre Defaux

Yves R Pascal

Jean B Llull

Jean-Francois J Letavernier

Jean-Pierre DeFaux

Bernard J Doat

New 2-(arylalkenyl)azacycloalkane derivatives which are ligands for sigma receptors, of the formula (I) ##STR1## in which: Ar is aryl or heteroaryl, optionally mono- to trisubstituted,

2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors

2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors

Allylaminoesters of the formula (I): ##STR1## in which: R.sub.1 is H or low-molecular-weight alkyl,

Allylaminoesters and their application in therapeutics

(+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylam ine of formula ##STR1## is a medicament of use in gastroenterology.

Use of

N-Cycloalkylalkylamines of formula I: ##STR1## in which: R1 is phenyl which is optionally mono-, di- or trisubstituted by halogens or lower alkyl, haloalkyl or lower alkoxy radicals, or is an aromatic heterocyclic radical having 5 to 7 chain members, in which the hetero atom is nitrogen, oxygen or sulphur,

N-cycloalkylalkylamines, process for their preparation, their use as a

Benzodiazepines of formula ##STR1## in which R.sup.9 is hydrogen or chlorine, R10 is phenyl, possibly substituted, R11 is hydrogen, R12 is oxygen or sulphur, R13 is an NH group, Ar is aromatic or heteroaromatic comprising one or more rings and in which, in particular, A is an ethylene or trimethylene bridge; e is 1 or 2; which are gastrin antagonists and/or central antagonists of cholecystokinin.

Benzodiazepines and applications in therapeutic practice

N-cycloalkylalkylamines, process for their preparation, their use as

Substituted ethylamines of the formula ##STR1## wherein R.sub.1 is phenyl optionally mono-, di- or trisubstituted by halogen, lower alkyl, lower haloalkyl or lower alkoxy, or is an aromatic heterocycle having 5 to 7 chains wherein the heteroatom is nitrogen, oxygen or sulfur,

Substituted ethylamines, their preparation process, their use as

Aminoalcohols of formula: ##STR1## in which R.sub.1 is alkyl, R.sub.2 H or alkyl, R.sub.3 in particularly H, alkyl, phenylakyl, alkanoyl, phenylalkanoyl, in which N, R.sub.2 and R.sub.3 together form a heterocycle saturated with 5 to 7 chain links. Analgesic medicaments.

Aminoalcohols, their preparation process and their applications,

Benzodiazepines of formula ##STR1## in which R.sub.1 is H of halogen, R.sub.2 is H or halogen, Ar is indolyl, phenyl, naphthyl, indolyl monosubstituted with a halogen or with a methoxy or phenyl mono-, di- or trisubstituted with a halogen or with a methoxy or with a trifluoromethyl group, and n is 2 or 3; and their optical isomers.

Benzodiazepines, process and intermediates for the preparation thereof

Lactulose-based laxative composition which is in the form of a jelly with a viscosity at 20.degree. C. measured on the Brookfield viscosimeter between 15,000 and 30,000 centipoises, a refractive index at 20.degree. C. between 1.430 and 1.445 and a pH between 3 and 4.

Laxative composition based on lactulose and its preparation process

Growing community of inventors

L'Hay-les-Roses, France

Alain P Calvet